These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25100952)

  • 1. How cognitive enhancement can change our duties.
    Santoni de Sio F; Faulmüller N; Vincent NA
    Front Syst Neurosci; 2014; 8():131. PubMed ID: 25100952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.
    Schleim S; Quednow BB
    Front Pharmacol; 2018; 9():3. PubMed ID: 29403383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
    Repantis D; Bovy L; Ohla K; Kühn S; Dresler M
    Psychopharmacology (Berl); 2021 Feb; 238(2):441-451. PubMed ID: 33201262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological neuroenhancement and brain doping : Chances and risks].
    Franke AG; Lieb K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):853-9. PubMed ID: 20700786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pills or Push-Ups? Effectiveness and Public Perception of Pharmacological and Non-Pharmacological Cognitive Enhancement.
    Caviola L; Faber NS
    Front Psychol; 2015; 6():1852. PubMed ID: 26696922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroenhancement].
    Gründer G; Bartsch T
    Nervenarzt; 2014 Dec; 85(12):1536-43. PubMed ID: 25403289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Doping for the brain].
    Iglseder B
    Z Gerontol Geriatr; 2018 Feb; 51(2):143-148. PubMed ID: 29209802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implications of methylphenidate use by healthy medical students and doctors in South Africa.
    Beyer C; Staunton C; Moodley K
    BMC Med Ethics; 2014 Mar; 15():20. PubMed ID: 24592964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background.
    Weiergräber M; Ehninger D; Broich K
    Med Monatsschr Pharm; 2017 Apr; 40(4):154-64. PubMed ID: 29952165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.
    Finke K; Dodds CM; Bublak P; Regenthal R; Baumann F; Manly T; Müller U
    Psychopharmacology (Berl); 2010 Jun; 210(3):317-29. PubMed ID: 20352415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In search of optimal psychoactivation: stimulants as cognitive performance enhancers.
    Rozenek EB; Górska M; Wilczyńska K; Waszkiewicz N
    Arh Hig Rada Toksikol; 2019 Sep; 70(3):150-159. PubMed ID: 32597132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Enhancement: Unanswered Questions About Human Psychology and Social Behavior.
    Racine E; Sattler S; Boehlen W
    Sci Eng Ethics; 2021 Mar; 27(2):19. PubMed ID: 33759032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine.
    Roberts CA; Jones A; Sumnall H; Gage SH; Montgomery C
    Eur Neuropsychopharmacol; 2020 Sep; 38():40-62. PubMed ID: 32709551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroscience in the Courtroom: From responsibility to dangerousness, ethical issues raised by the new French law].
    Gkotsi GM; Moulin V; Gasser J
    Encephale; 2015 Oct; 41(5):385-93. PubMed ID: 25439859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate.
    Maslen H; Faulmüller N; Savulescu J
    Front Syst Neurosci; 2014; 8():107. PubMed ID: 24999320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?
    Brühl AB; d'Angelo C; Sahakian BJ
    Brain Neurosci Adv; 2019; 3():2398212818816018. PubMed ID: 32166175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil, sleep deprivation, and cognitive function in military and medical settings.
    Westcott KJ
    Mil Med; 2005 Apr; 170(4):333-5. PubMed ID: 15916305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-creation of five key research priorities across law enforcement and public health: A methodological example and outcomes.
    Murray J; Heyman I; Dougall N; Wooff A; Aston E; Enang I
    J Psychiatr Ment Health Nurs; 2021 Feb; 28(1):3-15. PubMed ID: 32516840
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.